{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:28:34Z","timestamp":1793953714992,"version":"4.8.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijid.2026.108545","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:37:59Z","timestamp":1773765479000},"page":"108545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Host-directed therapy for tuberculosis: Repurposed drugs toward global tuberculosis elimination"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6704-9130","authenticated-orcid":false,"given":"Yi Hao","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Tarng","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting Huey","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1103-0451","authenticated-orcid":false,"given":"Catherine Wei Min","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108545_bib0001","series-title":"Global tuberculosis report 2025","year":"2025"},{"issue":"7","key":"10.1016\/j.ijid.2026.108545_bib0002","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/17476348.2021.1927718","article-title":"Extrapulmonary tuberculosis","volume":"15","author":"Sharma","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.ijid.2026.108545_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2025.102700","article-title":"The cytokine profiles of the inflammatory response in chronic granulomatous encephalitis caused by Mycobacterium tuberculosis do not influence the patient\u2019s clinical presentation","volume":"155","author":"Rivas-Castro","year":"2025","journal-title":"Tuberculosis"},{"issue":"3","key":"10.1016\/j.ijid.2026.108545_bib0004","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1440-1843.2010.01739.x","article-title":"The immunology of tuberculosis: from bench to bedside","volume":"15","author":"Dheda","year":"2010","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.ijid.2026.108545_bib0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016","article-title":"Cytokines and chemokines in Mycobacterium tuberculosis infection","volume":"4","author":"Domingo-Gonzalez","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijid.2026.108545_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.820134","article-title":"In the thick of it: formation of the tuberculous granuloma and its effects on host and therapeutic responses","volume":"13","author":"Cronan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2026.108545_bib0007","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3389\/fimmu.2020.00962","article-title":"Neutrophils in tuberculosis-associated inflammation and lung pathology","volume":"11","author":"Muefong","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ijid.2026.108545_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004917","article-title":"Neutrophil-derived MMP-8 drives AMPK-dependent matrix destruction in Human pulmonary tuberculosis","volume":"11","author":"Ong","year":"2015","journal-title":"PLoS Pathog"},{"issue":"17","key":"10.1016\/j.ijid.2026.108545_bib0009","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","article-title":"Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis","volume":"371","author":"Gillespie","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ijid.2026.108545_bib0010","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJMoa1315817","article-title":"A four-month gatifloxacin-containing regimen for treating tuberculosis","volume":"371","author":"Merle","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ijid.2026.108545_bib0011","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1314210","article-title":"High-dose rifapentine with moxifloxacin for pulmonary tuberculosis","volume":"371","author":"Jindani","year":"2014","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ijid.2026.108545_bib0012","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2502866","article-title":"Trial of high-dose oral rifampin in adults with tuberculous meningitis","volume":"393","author":"Meya","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108545_bib0013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fmed.2017.00171","article-title":"Host-directed therapeutic strategies for tuberculosis","volume":"4","author":"Kolloli","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0014","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s40001-025-02443-4","article-title":"Host-directed therapy for tuberculosis","volume":"30","author":"Tian","year":"2025","journal-title":"Eur J Med Res"},{"issue":"3","key":"10.1016\/j.ijid.2026.108545_bib0015","doi-asserted-by":"crossref","first-page":"2102263","DOI":"10.1183\/13993003.02263-2021","article-title":"Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes","volume":"60","author":"DiNardo","year":"2022","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ijid.2026.108545_bib0016","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018481","article-title":"Autophagy in tuberculosis","volume":"4","author":"Deretic","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijid.2026.108545_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1549572","article-title":"The role of metformin in tuberculosis control among TB and diabetes mellitus comorbid individuals","volume":"16","author":"Tetteh","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2026.108545_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101959","article-title":"Immune dysregulation of diabetes in tuberculosis","volume":"78","author":"Thong","year":"2025","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0019","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/jiz064","article-title":"Metformin alters human host responses to Mycobacterium tuberculosis in healthy subjects","volume":"220","author":"Lachmandas","year":"2019","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2026.108545_bib0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/cid\/ciab964","article-title":"Randomized trial of metformin with anti-tuberculosis drugs for early sputum conversion in adults with pulmonary tuberculosis","volume":"75","author":"Padmapriydarsini","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2026.108545_bib0021","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3201\/eid1605.091693","article-title":"Vitamin d deficiency and tuberculosis progression","volume":"16","author":"Talat","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"59","key":"10.1016\/j.ijid.2026.108545_bib0022","first-page":"325","article-title":"Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection","volume":"11","author":"Wu","year":"2011","journal-title":"Discov Med"},{"key":"10.1016\/j.ijid.2026.108545_bib0023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-13-22","volume":"13","author":"Salahuddin","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2026.108545_bib0024","doi-asserted-by":"crossref","first-page":"849","DOI":"10.12669\/pjms.344.14397","article-title":"Efficacy of vitamin D supplementation in achieving an early sputum conversion in smear positive pulmonary tuberculosis","volume":"34","author":"Afzal","year":"2018","journal-title":"Pak J Med Sci"},{"issue":"3","key":"10.1016\/j.ijid.2026.108545_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272682","article-title":"Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: a double blinded randomized control clinical trial","volume":"18","author":"Sinha","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijid.2026.108545_bib0026","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1056\/NEJMoa1915176","article-title":"Vitamin D supplements for prevention of tuberculosis infection and disease","volume":"383","author":"Ganmaa","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijid.2026.108545_bib0027","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/joim.12767","article-title":"Daily adjunctive therapy with vitamin D(3) and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia","volume":"284","author":"Bekele","year":"2018","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.ijid.2026.108545_bib0028","doi-asserted-by":"crossref","first-page":"1802003","DOI":"10.1183\/13993003.02003-2018","article-title":"Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data","volume":"53","author":"Jolliffe","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0029","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2396566","article-title":"Association of variant vitamin statuses and tuberculosis development: a systematic review and meta-analysis","volume":"56","author":"Zhou","year":"2024","journal-title":"Ann Med"},{"issue":"12","key":"10.1016\/j.ijid.2026.108545_bib0030","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/cid\/ciac326","article-title":"The impact of vitamin A deficiency on tuberculosis progression","volume":"75","author":"Podell","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0031","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13104-017-2737-z","article-title":"Low plasma vitamin A concentration is associated with tuberculosis in Moroccan population: a preliminary case control study","volume":"10","author":"Qrafli","year":"2017","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijid.2026.108545_bib0032","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.crimmu.2022.03.003","article-title":"All trans retinoic acid as a host-directed immunotherapy for tuberculosis","volume":"3","author":"Bahlool","year":"2022","journal-title":"Curr Res Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0033","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3945\/ajcn.110.001784","article-title":"The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial","volume":"93","author":"Visser","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.ijid.2026.108545_bib0034","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/j.1365-3156.2010.02638.x","article-title":"Randomized controlled trial of zinc and vitamin A as co-adjuvants for the treatment of pulmonary tuberculosis","volume":"15","author":"Lawson","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"5","key":"10.1016\/j.ijid.2026.108545_bib0035","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1039\/C9FO02751C","article-title":"Adjunctive vitamin A and D during pulmonary tuberculosis treatment: a randomized controlled trial with a 2\u00d72 factorial design","volume":"11","author":"Wang","year":"2020","journal-title":"Food Funct"},{"key":"10.1016\/j.ijid.2026.108545_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113686","article-title":"Mechanism of metformin regulation in central nervous system: progression and future perspectives","volume":"156","author":"Cao","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0037","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1186\/s12879-024-09367-0","article-title":"Prevalence of vitamin D deficiency and the effect of vitamin D3 supplementation on response to anti-tuberculosis therapy in patients with extrapulmonary tuberculosis","volume":"24","author":"Eletreby","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2026.108545_bib0038","doi-asserted-by":"crossref","DOI":"10.1038\/srep28171","article-title":"Autophagy induction targeting mTORC1 enhances Mycobacterium tuberculosis replication in HIV co-infected human macrophages","volume":"6","author":"Andersson","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ijid.2026.108545_bib0039","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2567.2002.01403.x","article-title":"The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis","volume":"106","author":"Rangel Moreno","year":"2002","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.ijid.2026.108545_bib0040","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0041","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13063-023-07448-0","volume":"24","author":"Arias","year":"2023","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.ijid.2026.108545_bib0042","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/23744235.2020.1778177","article-title":"Aspirin enhances the clinical efficacy of anti-tuberculosis therapy in pulmonary tuberculosis in patients with type 2 diabetes mellitus","volume":"52","author":"Wang","year":"2020","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.ijid.2026.108545_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100871","article-title":"Aspirin in tuberculous meningitis","volume":"35","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijid.2026.108545_bib0044","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33478","article-title":"A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults","volume":"7","author":"Mai","year":"2018","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.ijid.2026.108545_bib0045","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/jcp.25327","article-title":"Corticosteroid-induced MKP-1 represses pro-inflammatory cytokine secretion by enhancing activity of tristetraprolin (TTP) in ASM cells","volume":"231","author":"Prabhala","year":"2016","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0046","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-20188-2","article-title":"Dexamethasone inhibits Mycobacterium tuberculosis-induced glycolysis but preserves antimicrobial function in primary human macrophages","volume":"15","author":"Thong","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ijid.2026.108545_bib0047","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ccm.2014.08.014","article-title":"Steroids for acute respiratory distress syndrome?","volume":"35","author":"Hough","year":"2014","journal-title":"Clin Chest Med"},{"issue":"Pt.3","key":"10.1016\/j.ijid.2026.108545_bib0048","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1113\/jphysiol.2007.129007","article-title":"Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND","volume":"580","author":"Forster","year":"2007","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0049","first-page":"47","article-title":"Prednisolone: a beneficial and safe adjunct to antituberculosis treatment? A randomized controlled trial","volume":"3","author":"Bilaceroglu","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.ijid.2026.108545_bib0050","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/427995","article-title":"Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda","volume":"191","author":"Mayanja-Kizza","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2026.108545_bib0051","article-title":"Corticosteroids for managing tuberculous meningitis","volume":"4","author":"Prasad","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ijid.2026.108545_bib0052","doi-asserted-by":"crossref","first-page":"35","DOI":"10.55729\/2000-9666.1453","article-title":"The use of corticosteroids in patients with pleural and pericardial tuberculosis","volume":"15","author":"Sang","year":"2025","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"15","key":"10.1016\/j.ijid.2026.108545_bib0053","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMoa2216218","article-title":"Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adults","volume":"389","author":"Donovan","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ijid.2026.108545_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027821","article-title":"Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents","volume":"6","author":"Torok","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.201311-2106PP","article-title":"Tuberculosis, pulmonary cavitation, and matrix metalloproteinases","volume":"190","author":"Ong","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ijid.2026.108545_bib0056","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2011.05.005","article-title":"Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases","volume":"64","author":"Castro","year":"2011","journal-title":"Pharmacol Res"},{"issue":"15","key":"10.1016\/j.ijid.2026.108545_bib0057","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141895","article-title":"Doxycycline host-directed therapy in human pulmonary tuberculosis","volume":"131","author":"Miow","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ijid.2026.108545_bib0058","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1186\/s12879-016-1953-9","article-title":"Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease","volume":"16","author":"Majeed","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2026.108545_bib0059","doi-asserted-by":"crossref","first-page":"ofaf450","DOI":"10.1093\/ofid\/ofaf450","article-title":"Standardized infliximab regimen to treat severe central nervous system tuberculosis: a case series of 18 patients","volume":"12","author":"Benhard","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2026.108545_bib0060","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jpids\/piab094","article-title":"Infliximab for paradoxical reactions in pediatric central nervous system tuberculosis","volume":"10","author":"Abo","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"2","key":"10.1016\/j.ijid.2026.108545_bib0061","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/immuno2020021","article-title":"The immunomodulatory effects of statins on macrophages","volume":"2","author":"Sheridan","year":"2022","journal-title":"Immuno"},{"issue":"8","key":"10.1016\/j.ijid.2026.108545_bib0062","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","article-title":"Targeting AMPK by Statins: a potential therapeutic approach","volume":"81","author":"Dehnavi","year":"2021","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ijid.2026.108545_bib0063","first-page":"e7404","article-title":"Anti-tuberculous effects of statin therapy: a review of literature","volume":"12","author":"Tahir","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ijid.2026.108545_bib0064","first-page":"194","article-title":"Further insights into to the role of statins against active tuberculosis: systematic review and meta-analysis","volume":"30","author":"Meregildo-Rodriguez","year":"2022","journal-title":"Infez Med"},{"issue":"3","key":"10.1016\/j.ijid.2026.108545_bib0065","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5588\/ijtld.22.0548","article-title":"Atorvastatin accelerates Mycobacterium tuberculosis clearance in pulmonary TB: a randomised phase IIA trial","volume":"27","author":"Adewole","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"10.1016\/j.ijid.2026.108545_bib0066","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(23)00067-1","article-title":"Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial","volume":"23","author":"Cross","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108545_bib0067","article-title":"The impact of Mycobacterium tuberculosis on the macrophage cholesterol metabolism pathway","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ijid.2026.108545_bib0068","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/ph16070914","article-title":"The potential therapeutic application of simvastatin for brain complications and mechanisms of action","volume":"16","author":"Vuu","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijid.2026.108545_bib0069","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-2891-7-29","article-title":"The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk\/benefit profile","volume":"7","author":"Brambilla","year":"2008","journal-title":"Nutr J"},{"issue":"9","key":"10.1016\/j.ijid.2026.108545_bib0070","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300332","article-title":"Adjunctive N-acetylcysteine and lung function in pulmonary tuberculosis","volume":"3","author":"Wallis","year":"2024","journal-title":"NEJM Evid"},{"issue":"3","key":"10.1016\/j.ijid.2026.108545_bib0071","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/2229-3485.210450","article-title":"N-acetylcysteine as an add-on to directly observed therapy short-I therapy in fresh pulmonary tuberculosis patients: a randomized, placebo-controlled, double-blinded study","volume":"8","author":"Mahakalkar","year":"2017","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.ijid.2026.108545_bib0072","article-title":"Adjunct N-acetylcysteine treatment in hospitalized patients with HIV-associated tuberculosis dampens the oxidative stress in peripheral blood: results from the RIPENACTB Study trial","volume":"11","author":"Safe","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2026.108545_bib0073","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/brb3.208","article-title":"N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities","volume":"4","author":"Bavarsad Shahripour","year":"2014","journal-title":"Brain Behav"},{"key":"10.1016\/j.ijid.2026.108545_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631696","article-title":"Platelet activation and the immune response to tuberculosis","volume":"12","author":"Kirwan","year":"2021","journal-title":"Front Immunol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:08:08Z","timestamp":1793952488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226001803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":74,"alternative-id":["S1201971226001803"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108545","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host-directed therapy for tuberculosis: Repurposed drugs toward global tuberculosis elimination","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108545"}}